Pricing Log in Create free account

Armata Pharmaceuticals, Inc. (ARMP) vs Foghorn Therapeutics Inc. (FHTX)

Armata Pharmaceuticals, Inc. and Foghorn Therapeutics Inc. are both Biotechnology companies. Armata Pharmaceuticals, Inc. and Foghorn Therapeutics Inc. are of similar size ($113.1M and $111.5M). Foghorn Therapeutics Inc. grew revenue faster over the last twelve months: 52.0% against −19.3%. Foghorn Therapeutics Inc. has the higher net margin (−175.8% vs −3,467.0%) and the higher return on invested capital (0.00% vs −89.6%). Across the 16 metrics below, Foghorn Therapeutics Inc. leads on 12 and Armata Pharmaceuticals, Inc. on 4.

Valuation

Metric ARMP FHTX Biotechnology median
P/E n/m n/m 10.60
P/S 22.34 3.60 9.40
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.22 0.66
EV/Sales 69.17 (0.42) 9.02
Earnings yield (157.57%) (52.41%) (32.88%)
Free cash flow yield (20.83%) (63.84%) (23.13%)

Profitability

Metric ARMP FHTX Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin (734.19%) (198.04%) 0.00%
Net margin (3,467.04%) (175.78%) 0.00%
Free cash flow margin (465.34%) (229.49%) 0.00%
Return on equity 127.83% 81.90% (51.96%)
Return on assets (225.11%) (30.06%) (46.06%)
Return on invested capital (89.61%) 0.00% 0.00%

Growth

Metric ARMP FHTX Biotechnology median
Revenue growth (TTM) (19.29%) 51.98% 6.76%
EPS growth (last fiscal year) (440.18%) 25.32% 29.88%
Revenue growth, 5-year CAGR 42.90% 135.14% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARMP FHTX Biotechnology median
Debt to equity (1.23) 0.00 0.00
Current ratio 0.11 3.36 4.97
Net debt to EBITDA (7.07) 1.88 1.01

Dividend

Metric ARMP FHTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ARMP FHTX Biotechnology median
Market cap 111.54m 113.13m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack